Join and network with over 200 industry leaders at Discovery US: In-Person, where we will address the latest advancements in target identification, validation and HIT optimisation.
The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.
Join and network with over 200 industry leaders at Discovery US: In-Person, where we will address the latest advancements in target identification, validation and HIT optimisation.
The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling
Learn about key focus areas in drug design including AI in drug design: in chemical synthesis, target ID capabilities & lead identification/optimisation.
Join our 2-day innovation showcase situated alongside the main programme, which aims to inspire growth and create collaboration opportunities for all who attend.
Track 1: Identification & Validation of Novel Targets including RNA based Targets
Track 2: Animal and Disease Modelling, Organoid based Discovery, Organ On Chip development, 3D Media
Track 2: Hit Finding Technologies And Advancements
Track 3: Molecular Drug Design andMedicinal Chemistry
The 2022 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below are some of the confirmed speakers for 2022’s Discovery US: In-Person event
Bristol Myers Squibb
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.